In last trading session, Prime Medicine Inc (NASDAQ:PRME) saw 1.24 million shares changing hands with its beta currently measuring 1.86. Company’s recent per share price level of $3.13 trading at -$0.16 or -4.72% at ring of the bell on the day assigns it a market valuation of $410.53M. That closing price of PRME’s stock is at a discount of -212.14% from its 52-week high price of $9.77 and is indicating a premium of 28.12% from its 52-week low price of $2.25.
For Prime Medicine Inc (PRME), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.20. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.31 in the current quarter.
Prime Medicine Inc (NASDAQ:PRME) trade information
Upright in the red during last session for losing -4.72%, in the last five days PRME remained trading in the green while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $3.13 price level, adding 6.85% to its value on the day. Prime Medicine Inc’s shares saw a change of 7.19% in year-to-date performance and have moved 22.75% in past 5-day. Prime Medicine Inc (NASDAQ:PRME) showed a performance of 7.56% in past 30-days.
Wall Street analysts have assigned a consensus price target of 17 to the stock, which implies a rise of 81.59% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 23. It follows that stock’s current price would drop -283.39% in reaching the projected high whereas dropping to the targeted low would mean a loss of -283.39% for stock’s current value.
9 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 5.81M for the same. And 5 analysts are in estimates of company making revenue of 4.55M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -193.88% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 26.60% while estimates for its earnings growth in next 5 years are of 20.17%.
